scispace - formally typeset
A

Andrew J. Martin

Researcher at University of New South Wales

Publications -  897
Citations -  43053

Andrew J. Martin is an academic researcher from University of New South Wales. The author has contributed to research in topics: Medicine & Academic achievement. The author has an hindex of 84, co-authored 819 publications receiving 36203 citations. Previous affiliations of Andrew J. Martin include University of Western Australia & Max Planck Society.

Papers
More filters
Journal ArticleDOI

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.

TL;DR: The magnitude of PFS benefit is ethnicity-dependent but there is no interethnic differences in relative treatment-related toxicities and these findings may assist in the design and interpretation of trials, inform economic analyses, and stimulate pharmacogenomic research.
Journal ArticleDOI

Performance and Mastery Orientation of High School and University/College Students A Rasch Perspective

TL;DR: In this article, the authors assess performance and mastery orientation from a Rasch perspective among high school and university students and provide a complementary approach to the factor analytic methods typical in goal theory research.
Journal ArticleDOI

Examining the yields of growth feedback from science teachers and students' intrinsic valuing of science: Implications for student‐ and school‐level science achievement

TL;DR: In this paper, the authors investigated the relationship between growth feedback from science teachers to students and science achievement and found that at both the student-and school-level, growth feedback significantly predicted intrinsic valuing and significantly predicted achievement; growth feedback also had significant indirect effects of achievement via intrinsic.
Journal ArticleDOI

Characterization of pathogenic germline mutations in human Protein Kinases

TL;DR: Disease-associated mutations display sound differences with respect to neutral mutations: several amino acids are specific of each mutation type, different structural properties characterize each class and the distribution of pathogenic mutations within the consensus structure of the Protein Kinase domain is substantially different to that for non-pathogenic mutations.